Increased risk of bleeding with combined use of SSRIs and antiplatelet therapy after heart attacks
Monday, September 26, 2011 - 16:30
in Health & Medicine
Heart attack patients taking selective serotonin reuptake inhibitors (SSRIs) in combination with antiplatelet therapy -- acetylsalicylic acid (ASA), clopidogrel or both (dual antiplatelet therapy) -- are at higher risk of bleeding than patients taking ASA alone, according to a study in CMAJ.